Kerri L. Novak

3.8k total citations
111 papers, 2.4k citations indexed

About

Kerri L. Novak is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Kerri L. Novak has authored 111 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Genetics, 55 papers in Epidemiology and 51 papers in Surgery. Recurrent topics in Kerri L. Novak's work include Inflammatory Bowel Disease (69 papers), Microscopic Colitis (42 papers) and Appendicitis Diagnosis and Management (16 papers). Kerri L. Novak is often cited by papers focused on Inflammatory Bowel Disease (69 papers), Microscopic Colitis (42 papers) and Appendicitis Diagnosis and Management (16 papers). Kerri L. Novak collaborates with scholars based in Canada, United States and Australia. Kerri L. Novak's co-authors include Remo Panaccione, Gilaad G. Kaplan, Subrata Ghosh, Stephanie R. Wilson, Cynthia H. Seow, Christian Maaser, Cathy Lu, Christopher Ma, Torsten Kucharzik and Yvette Leung and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Kerri L. Novak

99 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kerri L. Novak Canada 27 1.8k 1.4k 939 436 302 111 2.4k
Claudio Papi Italy 27 1.6k 0.9× 1.4k 1.0× 1.0k 1.1× 153 0.4× 138 0.5× 84 2.3k
Antonio Rispo Italy 26 1.5k 0.9× 1.5k 1.1× 1.1k 1.2× 309 0.7× 165 0.5× 125 2.5k
Jean Yves Mary France 13 1.4k 0.8× 1.2k 0.8× 583 0.6× 133 0.3× 232 0.8× 26 2.6k
Simone Saibeni Italy 28 1.1k 0.6× 809 0.6× 850 0.9× 72 0.2× 165 0.5× 99 2.3k
Amanda Ricciuto Canada 17 1.7k 1.0× 1.3k 0.9× 849 0.9× 53 0.1× 201 0.7× 44 2.4k
A. D’Hoore Belgium 17 1.2k 0.7× 956 0.7× 923 1.0× 60 0.1× 209 0.7× 46 1.9k
J Y Mary France 17 1.4k 0.8× 1.1k 0.8× 734 0.8× 90 0.2× 184 0.6× 31 2.1k
Jasbir Dhaliwal United States 12 1.5k 0.8× 1.2k 0.9× 709 0.8× 51 0.1× 182 0.6× 22 2.0k
Francisco Portela Portugal 19 1.3k 0.7× 1.0k 0.8× 929 1.0× 45 0.1× 228 0.8× 129 2.1k
Gianmichele Meucci Italy 31 1.0k 0.6× 1.1k 0.8× 1.0k 1.1× 69 0.2× 670 2.2× 70 2.6k

Countries citing papers authored by Kerri L. Novak

Since Specialization
Citations

This map shows the geographic impact of Kerri L. Novak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerri L. Novak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerri L. Novak more than expected).

Fields of papers citing papers by Kerri L. Novak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerri L. Novak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerri L. Novak. The network helps show where Kerri L. Novak may publish in the future.

Co-authorship network of co-authors of Kerri L. Novak

This figure shows the co-authorship network connecting the top 25 collaborators of Kerri L. Novak. A scholar is included among the top collaborators of Kerri L. Novak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerri L. Novak. Kerri L. Novak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goodsall, Thomas M, Claire E. Parker, Alice S. Day, et al.. (2025). Expert Position Statement: Defining the Role of Intestinal Ultrasound in Assessing Constipation and Faecal Loading. Alimentary Pharmacology & Therapeutics. 62(8). 799–808. 2 indexed citations
2.
Frolkis, Alexandra, Lance L. Stein, Kerri L. Novak, et al.. (2025). Generalizability of Randomized Controlled Trials to Routine Clinical Care in Ulcerative Colitis. Inflammatory Bowel Diseases. 31(8). 2088–2096. 1 indexed citations
3.
Goodsall, Thomas M, Claire E. Parker, Alice S. Day, et al.. (2025). Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows? Authors' Reply. Alimentary Pharmacology & Therapeutics. 62(8). 855–856.
4.
Murguía-Favela, Luis, et al.. (2024). Normal Infant Immunologic Assessment and Uneventful Live Rotavirus Vaccination Despite Continuous Tofacitinib Exposure In Utero and During Breastfeeding. Crohn s & Colitis 360. 6(1). otae006–otae006. 7 indexed citations
5.
Tolsgaard, Martin G., K Gecse, Kerri L. Novak, et al.. (2024). Classifying Inflammation on Intestinal Ultrasound Images and Cineloops－A Learning Curve Study. Journal of Crohn s and Colitis. 18(12). 2076–2084. 3 indexed citations
6.
Rowan, Catherine, et al.. (2024). Tofacitinib as a Rescue Therapy for Ulcerative Colitis in Pregnancy. Inflammatory Bowel Diseases. 30(5). 868–870. 4 indexed citations
7.
Chavannes, Mallory, Lynn Kysh, Mariangela Allocca, et al.. (2023). Role of artificial intelligence in imaging and endoscopy for the diagnosis, monitoring and prognostication of inflammatory bowel disease: a scoping review protocol. BMJ Open Gastroenterology. 10(1). e001182–e001182.
8.
Novak, Kerri L., et al.. (2023). Intermittent Proton Pump Inhibitor Therapy in Low-Risk Non-Variceal Upper Gastrointestinal Bleeding May Be Significantly Cost-Saving. SHILAP Revista de lepidopterología. 10(7). 44–44. 1 indexed citations
9.
Hamilton, Patrick, Katherine A Buhler, John K MacDonald, et al.. (2023). Meta‐analysis: Placebo rates in microscopic colitis randomised trials and applications for future drug development using a historical control arm. Alimentary Pharmacology & Therapeutics. 57(8). 837–850. 1 indexed citations
10.
Smith, Philip J, Mathurin Fuméry, Rupert W. Leong, Kerri L. Novak, & Axel Dignaß. (2023). Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease. Expert Review of Clinical Immunology. 19(9). 1143–1156. 7 indexed citations
11.
Coward, Stephanie, Abdel Aziz Shaheen, Mark G. Swain, et al.. (2023). Incidence and Prevalence of Primary Sclerosing Cholangitis: A Meta-analysis of Population-based Studies. Inflammatory Bowel Diseases. 30(11). 2019–2026. 7 indexed citations
12.
Jones, Emma, Noelle Rohatinsky, Kerri L. Novak, et al.. (2022). Perceived Barriers to Professional Equality Among Women in Gastroenterology. Journal of the Canadian Association of Gastroenterology. 5(5). 226–233. 3 indexed citations
13.
14.
Voogd, F de, Rune Wilkens, K Gecse, et al.. (2020). A Reliability Study: Strong Inter-Observer Agreement of an Expert Panel for Intestinal Ultrasound in Ulcerative Colitis. Journal of Crohn s and Colitis. 15(8). 1284–1290. 59 indexed citations
15.
Ma, Christopher, Leonardo Guizzetti, Remo Panaccione, et al.. (2020). Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005–2016). Clinical Gastroenterology and Hepatology. 18(11). 2500–2509.e1. 26 indexed citations
16.
Ma, Christopher, Abdulelah Almutairdi, Divine Tanyingoh, et al.. (2019). Reduction in surgical stoma rates in Crohn's disease: a population‐based time trend analysis. Colorectal Disease. 21(11). 1279–1287. 12 indexed citations
17.
Lu, Cathy, Gilaad G. Kaplan, Divine Tanyingoh, et al.. (2018). P550 Early 12-week ultrasound response to treatment, used as a predictor of response at 6 months in Crohn’s disease: A prospective cohort study. Journal of Crohn s and Colitis. 12(supplement_1). S384–S384.
18.
Novak, Kerri L., Cathy Lu, Gilaad G. Kaplan, et al.. (2018). P526 Early sonographic response predicts long-term outcome in Crohn’s disease: A prospective cohort study. Journal of Crohn s and Colitis. 12(supplement_1). S372–S373. 1 indexed citations
19.
Ma, Christopher, Richard N. Fedorak, Gilaad G. Kaplan, et al.. (2017). Clinical, endoscopic and radiographic outcomes with ustekinumab in medically‐refractory Crohn's disease: real world experience from a multicentre cohort. Alimentary Pharmacology & Therapeutics. 45(9). 1232–1243. 123 indexed citations
20.
Ma, Irene, et al.. (2014). Ultrasound-Guided Paracentesis. MedEdPORTAL. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudio Papi Breakdown of academic impact, for papers by Antonio Rispo Breakdown of academic impact, for papers by Jean Yves Mary Breakdown of academic impact, for papers by Simone Saibeni Breakdown of academic impact, for papers by Amanda Ricciuto Breakdown of academic impact, for papers by A. D’Hoore Breakdown of academic impact, for papers by J Y Mary Breakdown of academic impact, for papers by Jasbir Dhaliwal Breakdown of academic impact, for papers by Francisco Portela Breakdown of academic impact, for papers by Gianmichele Meucci
Rankless by CCL
2026